Sleep Disordered Breathing and Multimorbidity: The Xiangya SDB Cohort Study
Launched by XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY · Dec 24, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Xiangya SDB Cohort Study is a clinical trial that aims to better understand sleep disordered breathing (SDB), which includes conditions like obstructive sleep apnea (OSA). SDB often occurs alongside other health issues, such as heart problems and cognitive decline, leading to a lower quality of life and increased health risks. This study will collect a variety of information from participants, including sleep patterns, daily habits, and other health conditions, to identify how SDB affects multiple body systems and to improve how we manage these issues.
To participate in this study, individuals must have suspected sleep disordered breathing and complete at least one overnight sleep monitoring test at the Xiangya Sleep Medicine Center. Participants will also need to fill out questionnaires and may receive assistance if needed. By joining this study, participants can expect to contribute to important research that could help identify high-risk individuals and improve treatment options for SDB and its related health problems. The study is currently recruiting participants of all ages and genders who agree to take part and provide informed consent.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1) Participants who were suspected of sleep disordered breathing must complete at least one overnight sleep monitoring at the Sleep Medicine Center at Xiangya Hospital.
- • 2) Participants can finish any assessment for each comorbid system by questionnaires, scales, physical examinations and tests, etc. independently or with the assistance.
- • 3) Participants agreed to participate in this study with signing an informed consent form.
- Exclusion Criteria:
- • Participants who refused to participate in this study or whose clinical data was lost.
About Xiangya Hospital Of Central South University
Xiangya Hospital of Central South University is a leading academic medical institution located in Changsha, China, renowned for its commitment to advancing healthcare through innovative clinical research and patient-centered care. As a key affiliate of Central South University, the hospital integrates clinical practice with medical education and research, fostering an environment that promotes the development of cutting-edge therapies and treatments. With a diverse array of specialized departments and a dedicated team of healthcare professionals, Xiangya Hospital actively participates in clinical trials aimed at enhancing medical knowledge and improving patient outcomes, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Changsha, Hunan, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported